attention deficit hyperactivity/impulsivity disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type
Conditions
Interventions
Intervention 1: The first intervention group: transdiagnostic cognitive-behavioral therapy. For this group, the unified protocol of transdiagnostic cognitive-behavioral therapy of Barlow et al. (2017
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
14 Years to 17 Years
Inclusion criteria
Inclusion criteria: Adolescent with attention deficit hyperactivity disorder receiving a fixed dose of the drug from at least one month before the start of the study age 14-17
Exclusion criteria
Exclusion criteria: Being diagnosed with bipolar mood disorder Being diagnosed with psychotic disorders Being diagnosed with substance use disorder Having serious suicidal thoughts Being diagnosed with conduct disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of attention deficit and hyperactivity/impulsivity based on Connors parent questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention, 3 months after the end of the intervention. Method of measurement: Connors parent questionnaire.;Symptoms of attention deficit and hyperactivity/impulsivity based on the integrated visual and auditory continuous performance test. Timepoint: Before the start of the intervention, after the end of the intervention, 3 months after the end of the intervention. Method of measurement: integrated visual and auditory continuous performance test.;Anxiety intensity. Timepoint: Before the start of the intervention, after the end of the intervention, 3 months after the end of the intervention. Method of measurement: Beck anxiety inventory.;Severity of depression. Timepoint: Before the start of the intervention, after the end of the intervention, 3 months after the end of the intervention. Method of measurement: Beck depression inventory.;Severity of emotional dysregulation. Timepoint: Before the start of the intervention, after the end of the intervention, 3 months after the end of the intervention. Method of measurement: Reactivity, intensity, polarity and stability scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Sadighpour
Iran University of Medical Sciences
Outcome results
None listed